Further Information:
The Health Products Regulatory Authority has been notified of a shortage of the following products:
- Celecoxib 100mg Hard Capsule – PA0711/241/001
- Imdur 60mg Prolonged Release Tablet – PA2129/001/001
- Lanoxin 500mcg/2ml Solution for Injection – PA1691/001/001
- Lanoxin PG 50mcg/ml Elixir – PA1691/001/002
- Lipantil Supra 145mg – PA2010/015/003
- Omesar 10mg Tablet – PA0865/011/001
- TOBI Podhaler 28mg Inhalation Powder; Capsule – EU/1/10/652/002
- Tracurium 10mg/ml Solution for Injection of Infusion – PA1691/029/001
- Venex XL 150mg Prolonged Release Capsule – PA0126/285/003
The following shortage has been resolved and supply has resumed to the Irish market:
- Beclazone 200mcg CFC-Free Inhaler – PA0436/021/011
- Celebrex 100mg Hard Capsule – PA0822/116/001
- Celecoxib 100mg Hard Capsule – PA2315/228/001
- Paramax 500mg/5mg Tablet – PA0540/154/001
- Steri-Neb Salamol 5mg/2.5ml Nebuliser Solution – PA1986/086/002
Please see the shortages section of the HPRA website for further information.
The HPRA will be sending weekly updates concerning medicinal product shortages. However, the above webpage will be updated in real time.